News & events
BULLETIN FROM Extraordinary GENERAL MEETING IN Q-LINEA AB (PUBL)
NOTICE OF EXTRAORDINARY GENERAL MEETING IN Q-LINEA AB (PUBL)
The shareholders in Q-linea AB (publ), reg. no. 556729-0217 (the “Company”) are hereby convened to an extraordinary general meeting...
Read more >
Interim report 1 January - 30 September 2024
Growing pipeline in the USThird quarter: 1 July – 30 September 2024Net sales amounted to SEK 0.6 million (3.0).The...
Read more >
Q-linea resolves to carry out a rights issue of approximately SEK 225 million and enters into an agreement for a bridge loan facility of approximately SEK 40 million
Q-linea AB (publ) (”Q-linea” or the “Company”) announces that the board of directors today has resolved to carry out...
Read more >
ASTar® evaluation begins at a US National Cancer Institute-designated cancer center
Q-linea AB (publ) (OMX: QLINEA) today announces the initiation of the first clinical evaluation of ASTar® at a National...
Read more >
Q-linea receives request for a 3-year contract at prominent Hospital in Milan, Italy
Q-linea AB (Publ) (OMX: QLINEA) announces that the company has received a formal request for a direct contract (Affidamento...
Read more >
Load more